Plavix Patent Infringement Trial Set For Jan. 22
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi/Bristol demonstrated that Apotex patent invalidity defense "lacks substantial merit," according to a court ruling granting a preliminary injunction blocking generics.
You may also be interested in...
Generic Plavix Supply Is Dwindling, McKesson Says
Wholesaler forecasts little additional sales of clopidogrel through the remainder of the year.
Generic Plavix Supply Is Dwindling, McKesson Says
Wholesaler forecasts little additional sales of clopidogrel through the remainder of the year.
Plavix "Irreparable Harm" Debated During Preliminary Injunction Appeal
Patent litigation case between Sanofi/Bristol and Apotex will follow in January.